Literature DB >> 22046796

[The lymph nodes status--prognostic factor in breast cancer].

V G Rugină1, D Mihalcea, Florentina Pricop.   

Abstract

AIM: The assessment of the survival rate according to axillary lymph nodes status in patients diagnosed with breast cancer.
MATERIAL AND METHODS: The study group included 206 women, treated in the 4th Obstetrics and Gynecology Clinic during 2002-2005. All patients were treated surgically with lymph nodes dissection. The analyzed variables included clinical and morphological features of both primary tumor and axillary lymph nodes. We have evaluated 5 years survival in relation to positivity and number of dissected lymph nodes. In order to determine the prognostic value of evaluated variables we have used Kaplan Meir method.
RESULTS: 77.7% of all patients were aged between 40 and 49 years old and 62.6% of them presented stage II tumors. Invasive ductal carcinoma was the most frequent histologic type (79.12%) and 71.2% of tumors were moderated of poorly differentiated, lymph nodes invasion being presented in 93 cases. Survival was significantly influenced by lymph node status (p = 0.0001), number of involved nodes (p = 0.0001), number of dissected nodes in pN0 patients (p = 0.0001) and application of adjuvant systemic therapy in pN0 patients (p = 0.0001).
CONCLUSIONS: The pathological examination of axillary nodes in breast cancer patients offers a valuable information regarding survival. The absence of lymph node metastases of 10 lymph nodes dissection or more, and the application of adjuvant systemic therapy favorably influence the survival.

Entities:  

Mesh:

Year:  2011        PMID: 22046796

Source DB:  PubMed          Journal:  Rev Med Chir Soc Med Nat Iasi        ISSN: 0048-7848


  4 in total

1.  Are breast cancer subtypes prognostic for nodal involvement and associated with clinicopathologic features at presentation in early-stage breast cancer?

Authors:  Tiffanie Jones; Hanmanth Neboori; H Wu; Qifeng Yang; Bruce G Haffty; Susan Evans; Susan Higgins; Meena S Moran
Journal:  Ann Surg Oncol       Date:  2013-05-10       Impact factor: 5.344

2.  Axillary lymph node status in multicentric breast tumors and breast tumors with nipple involvement.

Authors:  Murat Cakir; Ahmet Tekin; Tevfik Kücükkartallar; Celalettin Vatansev; Faruk Aksoy; Adil Kartal; Fatma B Tuncer
Journal:  Breast Care (Basel)       Date:  2012-10       Impact factor: 2.860

3.  Evaluation of the tracing effect of carbon nanoparticle and carbon nanoparticle-epirubicin suspension in axillary lymph node dissection for breast cancer treatment.

Authors:  Junze Du; Yongsong Zhang; Jia Ming; Jing Liu; Ling Zhong; Quankun Liang; Linjun Fan; Jun Jiang
Journal:  World J Surg Oncol       Date:  2016-06-22       Impact factor: 2.754

4.  Effect of node status on breast cancer survival by subtype: a single-center retrospective cohort study.

Authors:  Weibin Lian; Fangmeng Fu; Debo Chen; Chuan Wang
Journal:  Transl Cancer Res       Date:  2020-10       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.